DocDollars

Kowa Pharmaceuticals America, Inc.

AL · United States · Reporting entity ID 100000005379

Total reported 2019–2025
$4.04M
#773 of 2,960 reporting companies — 0% of all reported industry payments
$4.04M in general payments across 193,356 records.

How it breaks down

General payments $4,044,102

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Kowa Pharmaceuticals America, Inc. reported $4.04M to US doctors and teaching hospitals from 2019 to 2025, ranking #773 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 193,356 general payment records were filed.

Common questions about Kowa Pharmaceuticals America, Inc.

How much has Kowa Pharmaceuticals America, Inc. paid US doctors?

Kowa Pharmaceuticals America, Inc. reported $4,044,102 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,044,102 in general payments.

How does Kowa Pharmaceuticals America, Inc. rank among drug and device companies?

It ranks #773 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Kowa Pharmaceuticals America, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.